Tricuspid Valve Disease clinical trials at UC Irvine
1 research study open to eligible people
open to eligible people ages 18 years and up
To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Repair System in patients with symptomatic severe tricuspid regurgitation who have been determined to be at an intermediate or greater estimated risk of mortality with tricuspid valve surgery by the cardiac surgeon with concurrence by the local Heart Team
Irvine, California and other locations
Our lead scientists for Tricuspid Valve Disease research studies include Antonio Frangieh, MD.